Received Aug 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
received only the diluent portion of the vaccine; received only the diluent portion of the vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: received only the diluent portion of the vaccine) and inappropriate dose of vaccine administered (Verbatim: received only the diluent portion of the vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-JUL-2025 The pharmacist called in to request data about the possible administration of Priorix after a patient received only the diluent portion of the vaccine. The patient received only diluent of Priorix , which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This case is linked with case US2025095529, reported by the same reporter.; Sender's Comments: US-GSK-US2025095529:Separate case is created for unknown patient